Literature DB >> 32409581

AKT Ser/Thr kinase increases V-ATPase-dependent lysosomal acidification in response to amino acid starvation in mammalian cells.

Michael P Collins1, Laura A Stransky2, Michael Forgac3,2,4.   

Abstract

The vacuolar H+-ATPase (V-ATPase) is an ATP-dependent proton pump that is essential for cellular homeostasis. V-ATPase activity is controlled by the regulated assembly of the enzyme from its component V1 and V0 domains. We previously reported that amino acid starvation rapidly increases V-ATPase assembly and activity in mammalian lysosomes, but the signaling pathways controlling this effect are unknown. In testing inhibitors of pathways important for controlling cellular metabolism, we found here that the cAMP-dependent protein kinase (PKA) inhibitor H89 increases lysosomal V-ATPase activity and blocks any further change upon starvation. The AMP-activated protein kinase (AMPK) inhibitor dorsomorphin decreased lysosomal V-ATPase activity and also blocked any increase upon starvation. However, CRISPR-mediated gene editing revealed that PKA and AMPK are not required for the starvation-dependent increase in lysosomal V-ATPase activity, indicating that H89 and dorsomorphin modify V-ATPase activity through other cellular targets. We next found that the AKT Ser/Thr kinase (AKT) inhibitor MK2206 blocks the starvation-dependent increase in lysosomal V-ATPase activity without altering basal activity. Expression of AKT1 or AKT3, but not AKT2, was required for increased lysosomal V-ATPase activity in response to amino acid starvation in mouse fibroblasts. Finally, HEK293T cells expressing only AKT1 responded normally to starvation, whereas cells expressing only AKT2 displayed a significantly reduced increase in V-ATPase activity and assembly upon starvation. These results show that AKT is required for controlling the rapid response of lysosomal V-ATPase activity to changes in amino acid availability and that this response depends on specific AKT isoforms.
© 2020 Collins et al.

Entities:  

Keywords:  Akt PKB; CRISPR/Cas; MK2206; amino acid homeostasis; kinase signaling; lysosomal acidification; nutrient sensing; pH regulation; proton transport; vacuolar ATPase

Mesh:

Substances:

Year:  2020        PMID: 32409581      PMCID: PMC7363138          DOI: 10.1074/jbc.RA120.013223

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

Review 1.  Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology.

Authors:  Michael Forgac
Journal:  Nat Rev Mol Cell Biol       Date:  2007-11       Impact factor: 94.444

2.  Sp1 mediates glucose activation of the acetyl-CoA carboxylase promoter.

Authors:  S Daniel; K H Kim
Journal:  J Biol Chem       Date:  1996-01-19       Impact factor: 5.157

Review 3.  Targeting reversible disassembly as a mechanism of controlling V-ATPase activity.

Authors:  Patricia M Kane
Journal:  Curr Protein Pept Sci       Date:  2012-03       Impact factor: 3.272

4.  Genome engineering using the CRISPR-Cas9 system.

Authors:  F Ann Ran; Patrick D Hsu; Jason Wright; Vineeta Agarwala; David A Scott; Feng Zhang
Journal:  Nat Protoc       Date:  2013-10-24       Impact factor: 13.491

5.  Molecular cloning of a rat liver cDNA encoding the 16 kDa subunit of vacuolar H(+)-ATPases: organellar and tissue distribution of 16 kDa proteolipids.

Authors:  J Nezu; K Motojima; H Tamura; S Ohkuma
Journal:  J Biochem       Date:  1992-08       Impact factor: 3.387

Review 6.  The long physiological reach of the yeast vacuolar H+-ATPase.

Authors:  Patricia M Kane
Journal:  J Bioenerg Biomembr       Date:  2007-12       Impact factor: 2.945

Review 7.  Saccharomyces cerevisiae vacuolar H+-ATPase regulation by disassembly and reassembly: one structure and multiple signals.

Authors:  Karlett J Parra; Chun-Yuan Chan; Jun Chen
Journal:  Eukaryot Cell       Date:  2014-04-04

8.  Activation of PI3K, Akt, and ERK during early rotavirus infection leads to V-ATPase-dependent endosomal acidification required for uncoating.

Authors:  Mahmoud Soliman; Ja-Young Seo; Deok-Song Kim; Ji-Yun Kim; Jun-Gyu Park; Mia Madel Alfajaro; Yeong-Bin Baek; Eun-Hyo Cho; Joseph Kwon; Jong-Soon Choi; Mun-Il Kang; Sang-Ik Park; Kyoung-Oh Cho
Journal:  PLoS Pathog       Date:  2018-01-19       Impact factor: 6.823

Review 9.  Regulation of V-ATPase Assembly in Nutrient Sensing and Function of V-ATPases in Breast Cancer Metastasis.

Authors:  Michael P Collins; Michael Forgac
Journal:  Front Physiol       Date:  2018-07-13       Impact factor: 4.566

10.  The selectivity of protein kinase inhibitors: a further update.

Authors:  Jenny Bain; Lorna Plater; Matt Elliott; Natalia Shpiro; C James Hastie; Hilary McLauchlan; Iva Klevernic; J Simon C Arthur; Dario R Alessi; Philip Cohen
Journal:  Biochem J       Date:  2007-12-15       Impact factor: 3.857

View more
  5 in total

1.  DHHC17 Is a New Regulator of AMPK Signaling.

Authors:  Yingmin Sun; Keyong Du
Journal:  Mol Cell Biol       Date:  2022-08-01       Impact factor: 5.069

Review 2.  Role of Lysosomal Acidification Dysfunction in Mesenchymal Stem Cell Senescence.

Authors:  Weijun Zhang; Jinwu Bai; Kai Hang; Jianxiang Xu; Chengwei Zhou; Lijun Li; Zhongxiang Wang; Yibo Wang; Kanbin Wang; Deting Xue
Journal:  Front Cell Dev Biol       Date:  2022-02-07

Review 3.  Endosomal v-ATPase as a Sensor Determining Myocardial Substrate Preference.

Authors:  Shujin Wang; Yinying Han; Miranda Nabben; Dietbert Neumann; Joost J F P Luiken; Jan F C Glatz
Journal:  Metabolites       Date:  2022-06-22

4.  Direct control of lysosomal catabolic activity by mTORC1 through regulation of V-ATPase assembly.

Authors:  Edoardo Ratto; S Roy Chowdhury; Nora S Siefert; Martin Schneider; Marten Wittmann; Dominic Helm; Wilhelm Palm
Journal:  Nat Commun       Date:  2022-08-17       Impact factor: 17.694

Review 5.  The H+-ATPase (V-ATPase): from proton pump to signaling complex in health and disease.

Authors:  Amity F Eaton; Maria Merkulova; Dennis Brown
Journal:  Am J Physiol Cell Physiol       Date:  2020-12-16       Impact factor: 4.249

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.